Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

Read it at Phys.org ↗

← Front page